戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 us disease with high fatality, especially in developing nations.
2 site sanitation between 1990 and 2010 for 21 developing nations.
3  hundreds of thousands of deaths per year in developing nations.
4 y and mortality, particularly in children in developing nations.
5 range of infectious diseases, especially for developing nations.
6 munities and young scientists, especially in developing nations.
7 a significant component of health systems in developing nations.
8 ficant morbidity and mortality for humans in developing nations.
9 kin infections are particularly prevalent in developing nations.
10 the potential postsurgical infections in the developing nations.
11 ain cause of mortality in industrialized and developing nations.
12 nsufficiency is common in industrialized and developing nations.
13 tinuum among social groups and developed and developing nations.
14  globe, in both industrialized countries and developing nations.
15 pproximately 50% of all malignancies in some developing nations.
16 nology available to vaccine manufacturers in developing nations.
17 ty for overall health systems improvement in developing nations.
18 for high infant and child mortality rates in developing nations.
19 nd mortality, particularly among children in developing nations.
20 uman diarrheal disease in both developed and developing nations.
21 ts incidence is frequently underestimated in developing nations.
22 are a leading cause of infantile diarrhea in developing nations.
23 n infectious illness acquired by visitors to developing nations.
24 atively low capacity for clinical studies in developing nations.
25 y cost effective among immigrants from other developing nations.
26 d immigrants entering the United States from developing nations.
27 s attention on the health crises facing many developing nations.
28 creasing cause of morbidity and mortality in developing nations.
29  cancer are 176% higher in developed than in developing nations.
30 ageing of the population, particularly among developing nations.
31 ement of uremia-related CVD in developed and developing nations.
32 For new immigrants to the United States from developing nations, a strategy of detecting and treating
33 aviruses cause disease in industrialized and developing nations alike.
34 atural lands could increase food security in developing nations and preserve much of Earth's remainin
35 ae continues to pose a health threat in many developing nations and regions of the world struck by na
36 erms of access to care between developed vs. developing nations and the uneven representation of IBD
37                   Although more studies from developing nations are required, air pollution is a perv
38 or causes of morbidity and mortality in most developing nations around the world.
39 viral therapy (ART) is being administered in developing nations at unprecedented numbers following th
40 in part responsible for mercury emissions of developing nations (e.g., China, India, and Indonesia).
41 ervices drives income-based GHG emissions of developing nations (e.g., China, Indonesia, India, and B
42 itiative data in resource rich developed and developing nations further showed improved hospital mort
43 though the accessibility of HIV treatment in developing nations has increased dramatically over the p
44 indness and visual disability in many of the developing nations in Asia, Africa and the Middle East,
45 , Haiti, sub-Saharan Africa, South Asia, and developing nations in East Asia and the Pacific.
46 ll road construction is expected to occur in developing nations, including many regions that sustain
47 HIV therapy becomes more widely available in developing nations, it is clear that drug resistance wil
48 ency syndrome and other infectious diseases, developing nations must find ways to rapidly begin treat
49 nsferring transgenic plants or ag-biotech to developing nations, scientists from industrialized count
50 ading cause of maternal death, especially in developing nation settings.
51  incidence of urolithiasis is on the rise in developing nations; there is a need to address the most
52 infection in older children, particularly in developing nations where resources are scarce.
53 expenditure in HIV-infected populations from developing nations, where concurrent malnutrition and co
54  a primary constraint for crop production in developing nations, while in rich nations, intensive N f
55 knowledge and experience with hydroxyurea to developing nations with large medical burdens from SCA c
56 storage, and severely limits distribution to developing nations with limited infrastructure.
57 has recently increased in industrialized and developing nations, yet the population structure and vir

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。